The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Antibiotic resistance: a rundown of a global crisis
Open accessAbstract
The advent of multidrug resistance among pathogenic bacteria is imperiling the worth of antibiotics, which have previously transformed medical sciences. The crisis of antimicrobial resistance has been ascribed to the misuse of these agents and due to unavailability of newer drugs attributable to exigent regulatory requirements and reduced financial inducements. Comprehensive efforts are needed to minimize the pace of resistance by studying emergent microorganisms, resistance mechanisms, and antimicrobial agents. Multidisciplinary approaches are required across health care settings as well as environment and agriculture sectors. Progressive alternate approaches including probiotics, antibodies, and vaccines have shown promising results in trials that suggest the role of these alternatives as preventive or adjunct therapies in future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Origins and evolution of antibiotic resistance
Davies, J., & Davies, D. (2010) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00016-10 · Cited by 5,784
Liu, Y.-Y., Wang, Y., Walsh, T. R., Yi, L.-X., Zhang, R., Spencer, J., Doi, Y., Tian, G., Dong, B., Huang, X., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00424-7 · Cited by 5,398
The antibiotic resistance crisis: part 1: causes and threats.
Ventola, C. L. (2015) · PubMed · Cited by 4,516
Antibiotic resistance-the need for global solutions
Laxminarayan, R., Duse, A., Wattal, C., Zaidi, A. K. M., Wertheim, H. F. L., Sumpradit, N., Vlieghe, E., Hara, G. L., Gould, I. M., Goossens, H., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70318-9 · Cited by 4,439
Molecular mechanisms of antibiotic resistance
Blair, J. M. A., Webber, M. A., Baylay, A. J., Ogbolu, D. O., & Piddock, L. J. V. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3380 · Cited by 4,092
The antimicrobial activity of nanoparticles: present situation and prospects for the future
Wang, L., Hu, C., & Shao, L. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s121956 · Cited by 4,062
Global trends in antimicrobial use in food animals
Van Boeckel, T. P., Brower, C., Gilbert, M., Grenfell, B. T., Levin, S. A., Robinson, T. P., Teillant, A., & Laxminarayan, R. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1503141112 · Cited by 3,973
Antimicrobial resistance: a global multifaceted phenomenon
Prestinaci, F., Pezzotti, P., & Pantosti, A. (2015) · Pathogens and Global Health · doi:10.1179/2047773215y.0000000030 · Cited by 3,296
Mechanisms of Antibiotic Resistance
Munita, J. M., & Arias, C. A. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.vmbf-0016-2015 · Cited by 2,782
Understanding the mechanisms and drivers of antimicrobial resistance
Holmes, A. H., Moore, L. S. P., Sundsfjord, A., Steinbakk, M., Regmi, S., Karkey, A., Guerin, P. J., & Piddock, L. J. V. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00473-0 · Cited by 2,611
Drugs for bad bugs: confronting the challenges of antibacterial discovery
Payne, D. J., Gwynn, M. N., Holmes, D. J., & Pompliano, D. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2201 · Cited by 2,512
Food Animals and Antimicrobials: Impacts on Human Health
Marshall, B. M., & Levy, S. B. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00002-11 · Cited by 2,241
Antibiotics and Bacterial Resistance in the 21st Century
Fair, R. J., & Tor, Y. (2014) · Perspectives in Medicinal Chemistry · doi:10.4137/pmc.s14459 · Cited by 1,955
Microbiological effects of sublethal levels of antibiotics
Andersson, D. I., & Hughes, D. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3270 · Cited by 1,757
The expanding scope of antimicrobial peptide structures and their modes of action
Nguyen, L. T., Haney, E. F., & Vogel, H. J. (2011) · Trends in Biotechnology · doi:10.1016/j.tibtech.2011.05.001 · Cited by 1,604
An Enzyme from Bacteria able to Destroy Penicillin
ABRAHAM, E. P., & CHAIN, E. (1940) · Nature · doi:10.1038/146837a0 · Cited by 1,333
Bacterial phylogeny structures soil resistomes across habitats
Forsberg, K. J., Patel, S., Gibson, M. K., Lauber, C. L., Knight, R., Fierer, N., & Dantas, G. (2014) · Nature · doi:10.1038/nature13377 · Cited by 1,287
Wellington, E. M., Boxall, A. B., Cross, P., Feil, E. J., Gaze, W. H., Hawkey, P. M., Johnson-Rollings, A. S., Jones, D. L., Lee, N. M., Otten, W., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70317-1 · Cited by 1,122
The global threat of antimicrobial resistance: science for intervention.
Roca, I., Akova, M., Baquero, F., Carlet, J., Cavaleri, M., Coenen, S., Cohen, J., Findlay, D., Gyssens, I., Heure, O. E., et al. (2015) · New Microbes and New Infections · doi:10.1016/j.nmni.2015.02.007 · Cited by 1,106
Beceiro, A., Tomás, M., & Bou, G. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00059-12 · Cited by 1,070
The Antimicrobial Resistance Crisis: Causes, Consequences, and Management
Michael, C. A., Dominey-Howes, D., & Labbate, M. (2014) · Frontiers in Public Health · doi:10.3389/fpubh.2014.00145 · Cited by 974
Origins and evolution of antibiotic resistance.
DAVIES, J. E. (1996) · PubMed · Cited by 941
Woodford, N., Turton, J. F., & Livermore, D. M. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00268.x · Cited by 885
Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe
Cantón, R., Akóva, M., Carmeli, Y., Giske, C. G., Glupczynski, Y., Gniadkowski, M., Livermore, D. M., Miriagou, V., Naas, T., Rossolini, G. M., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03821.x · Cited by 883
Review of Antimicrobial Resistance in the Environment and Its Relevance to Environmental Regulators
Singer, A. C., Shaw, H., Rhodes, V., & Hart, A. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01728 · Cited by 844
Cationic host defense (antimicrobial) peptides
Brown, K. L., & Hancock, R. E. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.11.004 · Cited by 839
Agriculture and food animals as a source of antimicrobial-resistant bacteria
Economou, V., & Gousia, P. (2015) · Infection and Drug Resistance · doi:10.2147/idr.s55778 · Cited by 761
Combating Antimicrobial Resistance: Policy Recommendations to Save Lives
Infectious Diseases Society of America (IDSA) (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir153 · Cited by 733
Antibiotic Resistance in the Food Chain: A Developing Country-Perspective
Founou, L. L., Founou, R. C., & Essack, S. Y. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01881 · Cited by 714
Update on the antibiotic resistance crisis
Rossolini, G. M., Arena, F., Pecile, P., & Pollini, S. (2014) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.09.006 · Cited by 695
The role of antibiotics and antibiotic resistance in nature
Aminov, R. I. (2009) · Environmental Microbiology · doi:10.1111/j.1462-2920.2009.01972.x · Cited by 687
The multifaceted roles of antibiotics and antibiotic resistance in nature
Sengupta, S., Chattopadhyay, M. K., & Grossart, H.-P. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00047 · Cited by 629
Stokes, H. W., & Gillings, M. R. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00273.x · Cited by 619
Novel classes of antibiotics or more of the same?
Coates, A. R., Halls, G., & Hu, Y. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01250.x · Cited by 598
Worldwide Emergence of Extensively Drug-resistant Tuberculosis
Shah, N. S., Wright, A., Bai, G.-H., Barrera, L., Boulahbal, F., Martín-Casabona, N., Drobniewski, F., Gilpin, C., Havelková, M., Lepe, R., et al. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1303.061400 · Cited by 583
Kristiansson, E., Fick, J., Janzon, A., Grabic, R., Rutgersson, C., Weijdegård, B., Söderström, H., & Larsson, D. G. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017038 · Cited by 566
Martínez, J. L., & Baquero, F. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.4.647-679.2002 · Cited by 514
The role of natural environments in the evolution of resistance traits in pathogenic bacteria
Martinez, J. L. (2009) · Proceedings of the Royal Society B: Biological Sciences · doi:10.1098/rspb.2009.0320 · Cited by 513
Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era
DeLeo, F. R., & Chambers, H. F. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38226 · Cited by 512
The crisis of no new antibiotics—what is the way forward?
Piddock, L. J. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70316-4 · Cited by 500
Veterans Affairs Initiative to Prevent Methicillin-Resistant Staphylococcus aureus Infections
Jain, R., Kralovic, S. M., Evans, M. E., Ambrose, M., Simbartl, L. A., Obrosky, D. S., Render, M. L., Freyberg, R. W., Jernigan, J. A., Muder, R. R., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1007474 · Cited by 496
Antibiotic Resistance — Problems, Progress, and Prospects
Nathan, C., & Cars, O. (2014) · New England Journal of Medicine · doi:10.1056/nejmp1408040 · Cited by 491
The 10 × ‘20 Initiative: Pursuing a Global Commitment to Develop 10 New Antibacterial Drugs by 2020
(2010) · Clinical Infectious Diseases · doi:10.1086/652237 · Cited by 484
Maron, D. F., Smith, T. J., & Nachman, K. E. (2013) · Globalization and Health · doi:10.1186/1744-8603-9-48 · Cited by 481
Shaping bacterial genomes with integrative and conjugative elements
Burrus, V., & Waldor, M. K. (2004) · Research in Microbiology · doi:10.1016/j.resmic.2004.01.012 · Cited by 472
Seven Ways to Preserve the Miracle of Antibiotics
Bartlett, J. G., Gilbert, D. N., & Spellberg, B. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit070 · Cited by 468
Mechanisms of antibiotic resistance
Munita, J. M., & Arias, C. A. (2016) · Virulence Mechanisms of Bacterial Pathogens · doi:10.1128/9781555819286.ch17 · Cited by 421
Johnson, A. P., & Woodford, N. (2013) · Journal of Medical Microbiology · doi:10.1099/jmm.0.052555-0 · Cited by 411
Nathan, C. (2004) · Nature · doi:10.1038/431899a · Cited by 410
Biofilms and Antimicrobial Resistance
Patel, R. (2005) · Clinical Orthopaedics and Related Research · doi:10.1097/01.blo.0000175714.68624.74 · Cited by 390
Gene-culture coevolutionary theory
Feldman, M. W., & Laland, K. N. (1996) · Trends in Ecology & Evolution · doi:10.1016/0169-5347(96)10052-5 · Cited by 383
Therapeutic strategies to combat antibiotic resistance
Brooks, B. D., & Brooks, A. E. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.10.027 · Cited by 367
New antibiotic agents in the pipeline and how they can help overcome microbial resistance
Gould, I. M., & Bal, A. M. (2013) · Virulence · doi:10.4161/viru.22507 · Cited by 363
Access to medicines from a health system perspective
Bigdeli, M., Jacobs, B., Tomson, G., Laing, R., Ghaffar, A., Dujardin, B., & Van Damme, W. (2013) · Health Policy and Planning · doi:10.1093/heapol/czs108 · Cited by 348
Responses of Pseudomonas aeruginosa to antimicrobials
Morita, Y., Tomida, J., & Kawamura, Y. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00422 · Cited by 344
Tsai, Y.-K., Fung, C.-P., Lin, J.-C., Chen, J.-H., Chang, F.-Y., Chen, T.-L., & Siu, L. K. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01275-10 · Cited by 344
Gerding, D. N., Meyer, T., Lee, C., Cohen, S. H., Murthy, U. K., Poirier, A., Van Schooneveld, T. C., Pardi, D. S., Ramos, A., Barron, M. A., et al. (2015) · JAMA · doi:10.1001/jama.2015.3725 · Cited by 342
An enzyme from bacteria able to destroy penicillin. 1940.
Abraham, E. P., & Chain, E. (1988) · PubMed · Cited by 341
The Future of Antibiotics and Resistance: A Tribute to a Career of Leadership by John Bartlett
Spellberg, B., & Gilbert, D. N. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu392 · Cited by 324
Raqib, R., Sarker, P., Bergman, P., Ara, G., Lindh, M., Sack, D. A., Nasirul Islam, K. M., Gudmundsson, G. H., Andersson, J., & Agerberth, B. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602888103 · Cited by 317
De novo design and in vivo activity of conformationally restrained antimicrobial arylamide foldamers
Choi, S., Isaacs, A., Clements, D., Liu, D., Kim, H., Scott, R. W., Winkler, J. D., & DeGrado, W. F. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811818106 · Cited by 308
Antibiotic resistance management
Read, A. F., & Woods, R. J. (2014) · Evolution, Medicine, and Public Health · doi:10.1093/emph/eou024 · Cited by 302
Liu, A., Tran, L., Becket, E., Lee, K., Chinn, L., Park, E., Tran, K., & Miller, J. H. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00906-09 · Cited by 286
Something old, something new: revisiting natural products in antibiotic drug discovery
Wright, G. D. (2014) · Canadian Journal of Microbiology · doi:10.1139/cjm-2014-0063 · Cited by 283
A multifunctional bispecific antibody protects against Pseudomonas aeruginosa
DiGiandomenico, A., Keller, A. E., Gao, C., Rainey, G. J., Warrener, P., Camara, M. M., Bonnell, J., Fleming, R., Bezabeh, B., Dimasi, N., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009655 · Cited by 277
Combination therapies for combating antimicrobial resistance
Fischbach, M. A. (2011) · Current Opinion in Microbiology · doi:10.1016/j.mib.2011.08.003 · Cited by 259
Antibiotic resistance—the need for global solutions
(2014) · British Dental Journal · doi:10.1038/sj.bdj.2014.77 · Cited by 230
Antibiotic Resistance: A Public Health Crisis
Lushniak, B. D. (2014) · Public Health Reports® · doi:10.1177/003335491412900402 · Cited by 216
Pena-Miller, R., Laehnemann, D., Jansen, G., Fuentes-Hernandez, A., Rosenstiel, P., Schulenburg, H., & Beardmore, R. (2013) · PLoS Biology · doi:10.1371/journal.pbio.1001540 · Cited by 209
Drug Resistance and its Transfer in Salmonella typhimurium
ANDERSON, E. S., & LEWIS, M. J. (1965) · Nature · doi:10.1038/206579a0 · Cited by 202
Zhu, L., Lin, J., Ma, J., Cronan, J. E., & Wang, H. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01152-09 · Cited by 201
De novo designed synthetic mimics of antimicrobial peptides
Scott, R. W., DeGrado, W. F., & Tew, G. N. (2008) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2008.10.013 · Cited by 199
Schuch, R., Lee, H. M., Schneider, B. C., Sauve, K. L., Law, C., Khan, B. K., Rotolo, J. A., Horiuchi, Y., Couto, D. E., Raz, A., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit637 · Cited by 196
The Ethical Significance of Antimicrobial Resistance
Littmann, J., & Viens, A. M. (2015) · Public Health Ethics · doi:10.1093/phe/phv025 · Cited by 196
Evolution of Resistance to Quorum-Sensing Inhibitors
Kalia, V. C., Wood, T. K., & Kumar, P. (2014) · Microbial Ecology · doi:10.1007/s00248-013-0316-y · Cited by 192
LmrS Is a Multidrug Efflux Pump of the Major Facilitator Superfamily from Staphylococcus aureus
Floyd, J. L., Smith, K. P., Kumar, S. H., Floyd, J. T., & Varela, M. F. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00580-10 · Cited by 188
Hua, L., Hilliard, J. J., Shi, Y., Tkaczyk, C., Cheng, L. I., Yu, X., Datta, V., Ren, S., Feng, H., Zinsou, R., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02190-13 · Cited by 181
Epidemiology and clinical management of XDR-TB: a systematic review by TBNET
Sotgiu, G., Ferrara, G., Matteelli, A., Richardson, M. D., Centis, R., Ruesch-Gerdes, S., Toungoussova, O., Zellweger, J.-P., Spanevello, A., Cirillo, D., et al. (2009) · European Respiratory Journal · doi:10.1183/09031936.00168008 · Cited by 180
Current concepts on the virulence mechanisms of meticillin-resistant Staphylococcus aureus
Watkins, R. R., David, M. Z., & Salata, R. A. (2012) · Journal of Medical Microbiology · doi:10.1099/jmm.0.043513-0 · Cited by 178
Antivirulence as a new antibacterial approach for chemotherapy
Escaich, S. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2008.06.022 · Cited by 173
Understanding bacterial resistance to antimicrobial peptides: From the surface to deep inside
Maria-Neto, S., de Almeida, K. C., Macedo, M. L. R., & Franco, O. L. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.02.017 · Cited by 173
Mølbak, K. (2004) · Journal of Veterinary Medicine, Series B · doi:10.1111/j.1439-0450.2004.00788.x · Cited by 168
The Target of Daptomycin Is Absent from Escherichia coli and Other Gram-Negative Pathogens
Randall, C. P., Mariner, K. R., Chopra, I., & O'Neill, A. J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02005-12 · Cited by 163
Zoonotic Disease Programs for Enhancing Global Health Security
Belay, E. D., Kile, J. C., Hall, A. J., Behravesh, C. B., Parsons, M. B., Salyer, S. J., & Walke, H. T. (2017) · Emerging infectious diseases · doi:10.3201/eid2313.170544 · Cited by 159
High-level triclosan resistance in Pseudomonas aeruginosa is solely a result of efflux
Chuanchuen, R., Karkhoff-Schweizer, R. R., & Schweizer, H. P. (2003) · American Journal of Infection Control · doi:10.1067/mic.2003.11 · Cited by 156
Seral, C., Bambeke, F. V., & Tulkens, P. M. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.7.2283-2292.2003 · Cited by 152
Yeung, A. T. Y., Bains, M., & Hancock, R. E. W. (2010) · Journal of Bacteriology · doi:10.1128/jb.00911-10 · Cited by 146
Dubberke, E. R., Lee, C. H., Orenstein, R., Khanna, S., Hecht, G., & Gerding, D. N. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy259 · Cited by 140
Application of Nanoparticle Technologies in the Combat against Anti-Microbial Resistance
Kumar, M., Curtis, A. D. M., & Hoskins, C. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10010011 · Cited by 139
The Role of Compensatory Mutations in the Emergence of Drug Resistance
Handel, A., Regoes, R. R., & Antia, R. (2006) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0020137 · Cited by 130
The Chennai declaration: A roadmap to tackle the challenge of antimicrobial resistance
Ghafur, A. K., Mathai, D., Muruganathan, A., Jayalal, J., Kant, R., Chaudhary, D., Prabhash, K., Abraham, O., Gopalakrishnan, R., Ramasubramanian, V., et al. (2013) · Indian Journal of Cancer · doi:10.4103/0019-509x.104065 · Cited by 127
Lynch, J. P., Clark, N. M., & Zhanel, G. G. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.763030 · Cited by 126
Combating Antimicrobial Resistance: Policy Recommendations to Save Lives
(2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir154 · Cited by 125
A comprehensive regulatory framework to address the unmet need for new antibacterial treatments
Rex, J. H., Eisenstein, B. I., Alder, J. D., Goldberger, M. J., Meyer, R., Dane, A. L., Friedland, I. R., Knirsch, C. A., Sanhai, W. R., Tomayko, J. F., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70293-1 · Cited by 120
Strategies for achieving global collective action on antimicrobial resistance
Hoffman, S. J., Caleo, G., Daulaire, N., Elbe, S., Matsoso, P., Mossialos, E. A., Rizvi, Z., & Røttingen, J. (2015) · Bulletin of the World Health Organization · doi:10.2471/blt.15.153171 · Cited by 118
Lye, D. C., Earnest, A., Ling, M. L., Lee, T.-E., Yong, H.-C., Fisher, D. A., Krishnan, P., & Hsu, L. Y. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03606.x · Cited by 117
New Societal Approaches to Empowering Antibiotic Stewardship
Spellberg, B. J., Srinivasan, A., & Chambers, H. F. “. (2016) · JAMA · doi:10.1001/jama.2016.1346 · Cited by 115
Ghosh, A., Kar, R. K., Jana, J., Saha, A., Jana, B., Krishnamoorthy, J., Kumar, D., Ghosh, S., Chatterjee, S., & Bhunia, A. (2014) · ChemMedChem · doi:10.1002/cmdc.201402215 · Cited by 113
Kim, C. K., Mwangi, M. M., Chung, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082814 · Cited by 106
In silico tools for the analysis of antibiotic biosynthetic pathways
Weber, T. (2014) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2014.02.001 · Cited by 104
Advances in the diagnosis and treatment of Clostridium difficile infections
Peng, Z., Ling, L., Stratton, C. W., Li, C., Polage, C. R., Wu, B., & Tang, Y. (2018) · Emerging Microbes & Infections · doi:10.1038/s41426-017-0019-4 · Cited by 103
Time for a change: addressing R&D and commercialization challenges for antibacterials
Payne, D. J., Miller, L. F., Findlay, D. M., Anderson, J., & Marks, L. (2015) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2014.0086 · Cited by 102
Jun, S. Y., Jung, G. M., Yoon, S. J., Choi, Y., Koh, W. S., Moon, K., & Kang, S. H. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02232-13 · Cited by 102
Humphrey, T. J., Jorgensen, F., Frost, J. A., Wadda, H., Domingue, G., Elviss, N. C., Griggs, D. J., & Piddock, L. J. V. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.690-698.2005 · Cited by 101
The antibiotic pipeline: reviving research and development and speeding drugs to market
Luepke, K. H., & Mohr, J. (2017) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2017.1308251 · Cited by 98
Begier, E. M., Seiden, D., Patton, M., Zito, E. T., Severs, J. M., Cooper, D., Eiden, J., Gruber, W. C., Jansen, K. U., Anderson, A. S., et al. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.01.024 · Cited by 90
Westritschnig, K., Hochreiter, R., Wallner, G., Firbas, C., Schwameis, M., & Jilma, B. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.26565 · Cited by 86
Varshney, A. K., Kuzmicheva, G. A., Lin, J., Sunley, K. M., Bowling, R. A., Kwan, T.-Y., Mays, H. R., Rambhadran, A., Zhang, Y., Martin, R. L., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190537 · Cited by 80
Blake, K. L., & O'Neill, A. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks373 · Cited by 78
Functional study of the novel multidrug efflux pump KexD from Klebsiella pneumoniae
Ogawa, W., Onishi, M., Ni, R. T., Tsuchiya, T., & Kuroda, T. (2012) · Gene · doi:10.1016/j.gene.2012.02.008 · Cited by 77
Sirijatuphat, R., Sripanidkulchai, K., Boonyasiri, A., Rattanaumpawan, P., Supapueng, O., Kiratisin, P., & Thamlikitkul, V. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190132 · Cited by 76
Sohail, M. L., Rashid, A., Aslam, B., Waseem, M., Shahid, M., Akram, M., Khurshid, M., & Rasool, M. H. (2016) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-0111-2016 · Cited by 74
Self-citationHu, R., Liao, S.-T., Huang, C., Huang, Y.-W., & Yang, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051053 · Cited by 72
Gurieva, T., Bootsma, M., & Bonten, M. J. M. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis272 · Cited by 61
Hernandez, L. D., Racine, F., Xiao, L., DiNunzio, E. N., Hairston, N. N., Sheth, P. R., Murgolo, N., & Therien, A. G. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04433-14 · Cited by 54
Wyllie, D. H., Walker, A. S., Miller, R. R., Moore, C. E., Williamson, S. R., Schlackow, I., Finney, J. M., O’Connor, L., Peto, T., & Crook, D. W. (2011) · BMJ Open · doi:10.1136/bmjopen-2011-000160 · Cited by 54
Pro-Moieties of Antimicrobial Peptide Prodrugs
Forde, É., & Devocelle, M. C. (2015) · Molecules · doi:10.3390/molecules20011210 · Cited by 53
Chamchod, F., & Ruan, S. (2012) · Theoretical Biology and Medical Modelling · doi:10.1186/1742-4682-9-25 · Cited by 52
Voulgari, E., Poulou, A., Koumaki, V., & Tsakris, A. (2012) · Future Microbiology · doi:10.2217/fmb.12.130 · Cited by 51
Biological performance of a novel synthetic furanone-based antimicrobial
Baveja, J. K., Li, G., Nordon, R. E., Hume, E. B. H., Kumar, N., Willcox, M. D. P., & Poole-Warren, L. A. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2004.02.007 · Cited by 44
New edge of antibiotic development: antimicrobial peptides and corresponding resistance
Parachin, N. S., & Franco, O. L. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00147 · Cited by 43
Antibacterial antibodies gain traction
Morrison, C. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4770 · Cited by 39
Emergence of Is Aba 1 Harboring Carbapenem-Resistant Acinetobacter Baumannii Isolates in Pakistan
Khurshid, M., Rasool, M. H., Ashfaq, U. A., Aslam, B., & Waseem, M. (2017) · Future Microbiology · doi:10.2217/fmb-2017-0080 · Cited by 37
Self-citationMohsin, M., Raza, S., Roschanski, N., Guenther, S., Ali, A., & Schierack, P. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01945-16 · Cited by 34
Bergman, P., Norlin, A.-C., Hansen, S., & Björkhem‐Bergman, L. (2015) · BMC Research Notes · doi:10.1186/s13104-015-1378-3 · Cited by 30
Dangel, A., Ackermann, N., Abdel‐Hadi, O., Maier, R. H., Önder, K., François, P., Müller, C. W., Pané‐Farré, J., Engelmann, S., Schrenzel, J., et al. (2013) · The FASEB Journal · doi:10.1096/fj.13-234575 · Cited by 26
Cited by
Antimicrobial Resistance: Implications and Costs
Dadgostar, P. (2019) · Infection and Drug Resistance · doi:10.2147/idr.s234610 · Cited by 2,024
Metal-Based Nanoparticles as Antimicrobial Agents: An Overview
Sánchez-López, E., Gomes, D., Esteruelas, G., Bonilla, L., Lopez-Machado, A. L., Galindo, R., Cano, A., Espina, M., Ettcheto, M., Camins, A., et al. (2020) · Nanomaterials · doi:10.3390/nano10020292 · Cited by 1,474
Bacterial Antibiotic Resistance: The Most Critical Pathogens
Mancuso, G., Midiri, A., Gerace, E., & Biondo, C. (2021) · Pathogens · doi:10.3390/pathogens10101310 · Cited by 1,332
Antimicrobial resistance: Impacts, challenges, and future prospects
Ahmed, S. K., Hussein, S., Qurbani, K., Ibrahim, R. H., Fareeq, A., Mahmood, K. A., & Mohamed, M. G. (2024) · Journal of Medicine, Surgery, and Public Health · doi:10.1016/j.glmedi.2024.100081 · Cited by 1,213
Antibiotic resistance and persistence—implications for human health and treatment perspectives
Huemer, M., Mairpady Shambat, S., Brugger, S. D., & Zinkernagel, A. S. (2020) · The EMBO Reports · doi:10.15252/embr.202051034 · Cited by 850
Metadata
- Authors
- Aslam, B., Wang, W., Arshad, M. I., Khurshid, M., Muzammil, S., Rasool, M. H., Nisar, M. A., Alvi, R. F., Aslam, M. A., Qamar, M. U., Salamat, M. K. F., & Baloch, Z.
- Venue
- Infection and Drug Resistance
- Publisher
- Informa UK Limited
- Published
- 2018-10
- Volume
- Volume 11
- Pages
- 1645-1658
- ISSN
- 1178-6973 (ISSN-L)
- OpenAlex
- W2897109701
- Cited by
- 2,552
- References
- 126
- FWCI
- 118.41
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.